Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining a Gold Standard for Ischaemia: Effects of Interventional Revascularisation Versus Optimum Medical Therapy on Exercise Capacity in Patients With Stable Coronary Artery Disease

NCT02062593 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT02062593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02062593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining a Gold Standard for Ischaemia: Effects of Interventional Revascularisation Versus Optimum Medical Therapy on Exercise Capacity in Patients With Stable Coronary Artery Disease
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2013
Completion date
September 30, 2017
Enrollment
230 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

stable angina